膜型タイト結合タンパク質が担うがん悪性化機構の解明を通じた接着分子標的療法の構築

• Project/Area Number: 25K02473
• Research Category: Grant-in-Aid for Scientific Research (B)
• Allocation Type: Multi-year Fund
• Section: 一般
• Review Section: Basic Section 49020:Human pathology-related
• Research Institution: Asahikawa Medical College
• Principal Investigator: 高澤 啓 旭川医科大学, 医学部, 教授 (00593021)
• Project Period (FY): 2025-04-01 – 2028-03-31
• Project Status: Adopted (Fiscal Year 2025)
• Budget Amount: ¥18,850,000 (Direct Cost: ¥14,500,000、Indirect Cost: ¥4,350,000); Fiscal Year 2027: ¥6,110,000 (Direct Cost: ¥4,700,000、Indirect Cost: ¥1,410,000); Fiscal Year 2026: ¥6,500,000 (Direct Cost: ¥5,000,000、Indirect Cost: ¥1,500,000); Fiscal Year 2025: ¥6,240,000 (Direct Cost: ¥4,800,000、Indirect Cost: ¥1,440,000)